|
|
acylglycerol catabolic process
|
GO:0046464 |
11 |
0.999
|
|
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.999
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.997
|
|
|
|
neutral lipid catabolic process
|
GO:0046461 |
11 |
0.996
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.988
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.981
|
|
|
|
positive regulation of triglyceride catabolic process
|
GO:0010898 |
3 |
0.978
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.964
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.957
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.954
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.945
|
|
|
|
regulation of sequestering of triglyceride
|
GO:0010889 |
6 |
0.915
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.906
|
|
|
|
regulation of triglyceride catabolic process
|
GO:0010896 |
5 |
0.905
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.871
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.818
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.738
|
|
|
|
triglyceride mobilization
|
GO:0006642 |
5 |
0.689
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.679
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.601
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.536
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.534
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.502
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.492
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.475
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.472
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.464
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.454
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.446
|
|
|
|
sequestering of triglyceride
|
GO:0030730 |
6 |
0.438
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.429
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.407
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.390
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.379
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.376
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.350
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.331
|
|
|
|
positive regulation of lipid catabolic process
|
GO:0050996 |
6 |
0.330
|
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.311
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.308
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.297
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.297
|
|
|
|
positive regulation of triglyceride lipase activity
|
GO:0061365 |
3 |
0.297
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.286
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.284
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.266
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.265
|
|
|
|
regulation of fatty acid beta oxidation
|
GO:0031998 |
1 |
0.263
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.253
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.252
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.216
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.206
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.196
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.191
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.184
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.182
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.180
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.179
|
|
|
|
negative regulation of lipid catabolic process
|
GO:0050995 |
6 |
0.176
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.169
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.167
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.159
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.156
|
|
|
|
negative regulation of sequestering of triglyceride
|
GO:0010891 |
2 |
0.155
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.151
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.145
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.142
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.132
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.131
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.128
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.124
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.118
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.117
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.110
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.110
|
|
|
|
negative regulation of fatty acid oxidation
|
GO:0046322 |
5 |
0.107
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.104
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.101
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.098
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.097
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.095
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.094
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.091
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.091
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.090
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.089
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.087
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.087
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.087
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.087
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.085
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.081
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.081
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.080
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.080
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.079
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.079
|
|
|
|
negative regulation of triglyceride metabolic process
|
GO:0090209 |
4 |
0.077
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.077
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.077
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.076
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.076
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.075
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.074
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.072
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.071
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.070
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.070
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.069
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.069
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.069
|
|
|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
0.068
|
|
|
|
negative regulation of fatty acid metabolic process
|
GO:0045922 |
10 |
0.068
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.068
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.066
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.064
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.062
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.061
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.061
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.060
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.059
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.059
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.058
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.057
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.057
|
|
|
|
lipid particle organization
|
GO:0034389 |
7 |
0.057
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.056
|
|
|
|
positive regulation of triglyceride biosynthetic process
|
GO:0010867 |
6 |
0.056
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.055
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.055
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.055
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.054
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.054
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.053
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.053
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.052
|
|
|
|
triglyceride catabolic process
|
GO:0019433 |
9 |
0.052
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.051
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.051
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.050
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.050
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.050
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.050
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.049
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.048
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.047
|
|
|
|
positive regulation of fatty acid beta oxidation
|
GO:0032000 |
1 |
0.047
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.046
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.046
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.046
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.045
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.045
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.045
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.045
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.045
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.044
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.044
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.044
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
16 |
0.043
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.042
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.041
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.041
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.041
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.041
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.041
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.040
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.040
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.040
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.039
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.039
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.039
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.039
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.039
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.039
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.039
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.039
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.038
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.038
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.038
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.038
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.037
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.037
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.036
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.036
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.036
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.036
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.035
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.035
|
|
|
|
high density lipoprotein particle remodeling
|
GO:0034375 |
4 |
0.035
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.035
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.034
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.034
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.034
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.034
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.034
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.034
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.034
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.033
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.033
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.033
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.033
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.033
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.032
|
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.032
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.032
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.032
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.032
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.032
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.032
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.032
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.032
|
|
|
|
endoplasmic reticulum organization
|
GO:0007029 |
10 |
0.031
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.031
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.031
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.031
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.031
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.030
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.030
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.030
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.030
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.030
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.030
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.030
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.030
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.030
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.029
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.029
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.029
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.029
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.029
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.029
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.029
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.029
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.028
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.028
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.028
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.028
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.028
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.028
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.028
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.028
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.027
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.027
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.027
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.027
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.027
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.027
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.027
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.027
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.026
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.026
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.026
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.026
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.026
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.026
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.026
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.025
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.025
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.025
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.025
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.025
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.025
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.025
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.025
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.025
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.024
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.024
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.024
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.024
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.024
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.024
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.024
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.024
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.024
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.024
|
|
|
|
ruffle organization
|
GO:0031529 |
16 |
0.024
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.024
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.024
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.024
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.024
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.024
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.024
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.023
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.023
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.023
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.023
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.023
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.023
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.023
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.022
|
|
|
|
regulation of phospholipid catabolic process
|
GO:0060696 |
2 |
0.022
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.022
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.022
|
|
|
|
negative regulation of lipid storage
|
GO:0010888 |
6 |
0.022
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.022
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.022
|
|
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.022
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.022
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.022
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.022
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.022
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.022
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.022
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.022
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.022
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.022
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.022
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.021
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.021
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.021
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.021
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.021
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.021
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.021
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.021
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.021
|
|
|
|
negative regulation of cellular amide metabolic process
|
GO:0034249 |
4 |
0.021
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.021
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.021
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.021
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.021
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.021
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.020
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.020
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.020
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.020
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.020
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.020
|
|
|
|
corticotropin releasing hormone secretion
|
GO:0043396 |
2 |
0.020
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.020
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.020
|
|
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.020
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.020
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.020
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.020
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.020
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.020
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.020
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.020
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.020
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.020
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.020
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.020
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.019
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.019
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.019
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.019
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.019
|
|
|
|
cholesterol biosynthetic process
|
GO:0006695 |
15 |
0.019
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.019
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.019
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.019
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.019
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.019
|
|
|
|
peroxisome proliferator activated receptor signaling pathway
|
GO:0035357 |
9 |
0.019
|
|
|
|
nuclear envelope organization
|
GO:0006998 |
11 |
0.019
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.019
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.019
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.019
|
|
|
|
sterol import
|
GO:0035376 |
2 |
0.019
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.019
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.019
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.018
|
|
|
|
nucleus organization
|
GO:0006997 |
45 |
0.018
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.018
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.018
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.018
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.018
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.018
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.018
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.018
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.018
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.018
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.018
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.018
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.018
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.018
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.018
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.018
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.018
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.018
|
|
|
|
membrane disassembly
|
GO:0030397 |
1 |
0.018
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.018
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.018
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.017
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.017
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.017
|
|
|
|
positive regulation of phagocytosis engulfment
|
GO:0060100 |
3 |
0.017
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.017
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.017
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
|
|
|
nadph regeneration
|
GO:0006740 |
2 |
0.017
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.017
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.017
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.017
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.017
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.017
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.017
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.017
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.017
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.017
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.016
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.016
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.016
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.016
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.016
|
|
|
|
response to amine
|
GO:0014075 |
16 |
0.016
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.016
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.016
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.016
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.016
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.016
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.016
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.016
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.016
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.016
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.016
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.016
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.016
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.016
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.016
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.016
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.016
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.016
|
|
|
|
regulation of beta amyloid clearance
|
GO:1900221 |
1 |
0.016
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.016
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.016
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.016
|
|
|
|
ethanolamine containing compound metabolic process
|
GO:0042439 |
18 |
0.015
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.015
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.015
|
|
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
4 |
0.015
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.015
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.015
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.015
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.015
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.015
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:0051044 |
3 |
0.015
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.015
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.015
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.015
|
|
|
|
phosphatidylcholine metabolic process
|
GO:0046470 |
13 |
0.015
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.015
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.015
|
|
